(Incorporated in the Cayman Islands)

Established in 2007, we are a Hong Kong-based pain management and health services provider with over 16 years of experience in pain management and functional enhancement, under our “ANKH” brand. ANKH, stands for “A New Key to Health”, testifying our aspiration to be a health brand not only for alleviating physical pain but also for allowing individuals to emanate joy, health, and vitality from within and throughout.

We offer a broad range of non-surgical, non-invasive, and non-pharmacological pain management treatment and therapies, functional enhancement therapies, and topical use and dietary supplements health products, to our clients to eliminate pain points, invigorate blood circulation, enhance the body’s detoxification function, strengthen muscle and joint, and ultimately enhance functionality.

The theoretical and technological underpinning of our therapies and treatment, the “RDS+” (Restore, Detox, and Strengthen) approach to pain management and function enhancement, combines the wisdom of Traditional Chinese Medicine (“TCM”) and various energy-based treatment and therapy devices we sourced internationally, to enable our trained therapists performing broad range of treatment procedures involving the use of laser, bioelectrical current, electromagnetic, radiofrequency, and ultrasound, and to provide symptomatic relief and addressing root cause of our client’s pain and subhealth condition, reducing the chances of pain and condition recurrence, ultimately helping our clients to regain health and vitality.

Our “RDS+” approach to pain management and function enhancement is inspired by the concept of meridian system (Jing Luo) of Traditional Chinese Medicine. Jing Luo, commonly translated as meridians, is a concept in Traditional Chinese Medicine describing the network of pathways through which vital energy, or Qi, and blood circulate in the body. According to the Traditional Chinese Medicine theory, the stagnation, blockage, or the deficiency of the flow of Qi, are the root cause of pain and illness. Our RDS+ approach to pain management and function enhancement combines the wisdom of Traditional Chinese Medicine, the modern technology and various advanced energy-based treatment devices, to restore, detox, and strengthen the healthy flow of Qi, and to ease and eliminate acute and chronic musculoskeletal and nociceptive pain, alleviate muscle fatigue, relieve muscle stiffness, remove stagnation, detoxing metabolic wastes, improve blood circulation, strengthen muscle and joints, and ultimately enhance body functionality.

Apart from our pain management treatment services, we offer various types of Over-the-Counter topical use products, including creams, moisturizers, ointments, and dietary supplement products at our service centers and online shop on our website. As of the date of the prospectus, we offer topical use products in private-label under our brands, “ANKH Skin Power” and “30s Ice & Warm Rescue,” and a branded product, “CHARISMS”, sourced from a third party. We also offer private-label dietary supplement products under our brand names, “Super 17 Probiotics”, “40+ Knee Expert”, “A Plus Joint Expert”, and “Day Day Detox”.

We provide our pain management and function enhancement services in three service centers that are situated in prime commercial buildings in Hong Kong, and exquisitely renovated to provide an exclusive experience for our valued clients. All our service centers are well-equipped with energy-based treatment devices. In each service center, our team of Chinese Medicine Practitioners, consultants, and trained therapists provides consultation, assessment, treatment, pain management, rehabilitation, and education for a wide array of pain and subhealth conditions across various demographics.

Note: Net income and revenue are in U.S. dollars for the 12 months that ended Sept. 30, 2024.

(Note: Anew Health Ltd. filed its  F-1 on March 7, 2025, and disclosed the terms for its IPO: The company is offering 5.0 million shares at an assumed IPO price of $4.00 to raise $20.0 million.)